Harvard carries clout, not just on a resume but in matters of actual importance–and the school is going to do something good with it.

Along with Yale, University of Pennsylvania, Brown, and Boston University–the latter three of which Bloomberg News did not deem worthy of including in the headline of its article today–Harvard is releasing a set of provisions that will dictate how drugs developed on campus will be marketed.

Read more after the jump.